Methods of inducing terminal differentiation

Details for Australian Patent Application No. 2003213684 (hide)

Owner Sloan-Kettering Institute for Cancer Research Merck HDAC Research, LLC

Inventors Miller, Thomas A; Richon, Victoria, M.; Chiao, Judy H; Kelly, W Kevin

Agent Cullen & Co

Pub. Number AU-B-2003213684

PCT Number PCT/US03/06451

PCT Pub. Number WO2003/075839

Priority 60/361,759 04.03.02 US

Filing date 4 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 26 April 2007

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/361,759 04.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213684

26 April 2007 Amendment Made

  The nature of the amendment is: Amend co-inventor names to read Miller, Thomas A; Richon, Victoria, M; Chiao, Judy H and Kelly, W Kevin

26 April 2007 Assignment before Grant

  Sloan-Kettering Institute for Cancer Research; Aton Pharma, Inc. The application has been assigned to Sloan-Kettering Institute for Cancer Research; Merck HDAC Research, LLC

26 April 2007 Application Accepted

  Published as AU-B-2003213684

30 August 2007 Standard Patent Sealed

12 June 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 08 May 2008. Address for service in Australia - Cullen & Co 239 George Street Brisbane QLD 4000

23 October 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 May 2008

1 July 2010 Extension of Term of Standard Patents

  Sloan-Kettering Institute for Cancer Research; Merck HDAC Research, LLC The earliest first regulatory approval date provided by the patentee 17 Dec 2009 For the goods ZOLINZA vorinostat

23 September 2010 Extension of Term of Standard Patents

  Sloan-Kettering Institute for Cancer Research; Merck HDAC Research, LLC The earliest first regulatory approval date provided by the patentee 17 Dec 2009 For the goods ZOLINZA vorinostat Address for service in Australia: Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

17 February 2011 Extension granted

  Sloan-Kettering Institute for Cancer Research; Merck HDAC Research, LLC The earliest first regulatory approval date provided by the patentee 17 Dec 2009 For the goods ZOLINZA vorinostat Extension of Term of patent pursuant to Section 77 expires on 17 Dec 2024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213685-Flow restrictor

2003213683-CLEANSING COMPOSITIONS WITH MILK PROTEIN AND AROMATHERAPY